BioWorld MedTech

May 25, 2010

Regulatory path uncertainty a big-time concern for VCs

MINNEAPOLIS – If you want to know about the state of healthcare investing, who better to ask than those who pull the trigger, or maybe don't? (Medical Device Daily) Read More

PVI helps assess hypotension risk during anesthesia

Washington roundup: IRS publishes guidelines for healthcare reform tax credit

Medispec develops 'shocking' solution for vessel growth

Report from Europe: SyntheMed's adhesion barrier film gets CE mark approval

Coming Wednesday in MDD Perspectives: Technology isn't silverbullet,without human change

Deals roundup: ZyGEM acquires Microlab, plans to integrate products

Court report: Hospital settles pay-to-play qui tam suit for $108 million

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 27, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...